Nebulizers Global Market Report 2024

The nebulizers market size has grown strongly in recent years. It will grow from $1.16 billion in 2023 to $1.25 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to the increased incidence of chronic respiratory diseases and rising healthcare expenditure in emerging economies.

The nebulizers market size is expected to see strong growth in the next few years. It will grow to $1.72 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated growth in the forecast period can be attributed to the increasing geriatric population, growing demand for home healthcare devices such as portable nebulizers, increased acceptance of mesh nebulizers, the growing prevalence of COVID-19 globally, and increased consumption of tobacco and alcohol. Major trends in the forecast period include the development of connected nebulizers, a focus on the development of lightweight portable nebulizers, utilizing vibrating technology for new nebulizers, and initiatives to develop products from environmentally friendly materials.

The anticipated rise in the global geriatric population is expected to drive the utilization of respiratory care devices, including nebulizers, in the foreseeable future. The World Health Organization (WHO) projects that by 2050, the worldwide population aged 60 and above will reach 2 billion, up from 900 million. According to the United Nations, the global population of individuals aged 65 and older was approximately 727 million in 2020, and this figure is predicted to nearly double to over 1.5 billion by 2050. The elderly are more vulnerable to respiratory ailments such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and recent health crises such as COVID-19, given factors such as a gradual decline in immune function. Consequently, the growth of the geriatric demographic is expected to be a driving force for the nebulizers market.

The growing demand for telemedicine is poised to be a significant factor propelling the expansion of the nebulizers market. Telemedicine, also known as telehealth, involves delivering healthcare services remotely through telecommunications technology. Integrating nebulizer usage into telemedicine offers patients the advantages of remote consultations and personalized care plans, particularly for managing chronic respiratory conditions. In January 2023, FAIR Health Inc. reported a 7.3% national increase in telemedicine use, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023.

Major players in the nebulizers market are obtaining FDA approvals for innovative devices such as Smart Nebulizers to enhance their market profitability. Smart nebulizers utilize digital technology to optimize the delivery of aerosol drugs to the lungs. In June 2022, Vectura Group Limited, a UK-based pharmaceutical company, announced FDA approval for its Smart Nebulizers designed to improve pediatric asthma treatment. These smart nebulizers efficiently distribute aerosol to the lungs, considering the patient's specific breathing capacity. They can be utilized to treat various respiratory conditions, including asthma, bronchitis, sore throats, acute tracheitis, and chronic tracheitis.

Major companies in the nebulizers market are forming strategic partnerships. In April 2021, the Asthma and Allergy Foundation of America, a US-based non-profit organization, entered into a partnership with Omron Healthcare Co. Ltd., a Japan-based healthcare company. The collaboration focuses on delivering ongoing support, advocacy, and education to alleviate the burdens of asthma and allergies. Additionally, the partnership is directed at providing respiratory medical treatment to underserved regions that often lack access to high-quality healthcare services.

Major companies operating in the nebulizers market report are Koninklijke Philips N.V., Vyaire Medical, Inc., Aerogen, Omron Corporation, PARI, GF Health Products, Medline Industries, Trudell Medical International, Briggs Healthcare, Feellife Health Inc., CF Pharmtech Inc., Hoyo Scitech Co., Ltd., Simzon, Yirdoc (Qingdao Future Medical Technology Co., Ltd.), Healthgenie, Meditive, Agaro, Dr Trust, Dr. Morepen, Handyneb, Nuwik, Philips Healthcare, Nagashima Medical Instruments co., Ltd., Citizen Systems Japan Co., Shenzhen Bi-rich, Yuyao Dengyue Medical Devices Co., Ltd., Shenzhen Aeon Technology Co., Ltd., EverGreen, MediSave, Scala, Porex, ResMed, Masimo Corporation, Draegerwerk AG, Fisher & Paykel Healthcare Limited, Vectura, GE Healthcare, AstraZenca, Medtronics, B. Braun Melsungen, Beikohn, Vostok Service, Technoavia, TD Trakt, Respiratorniy Kompleks, Alvateks, Dixion Russia, Triton Electronics Systems, Ltd., 3M Company, Johnson and Johnson, Dynarex Corporation, Honeywell, Kimberly-Clark Corporation, BD, Moldex-Metric, Agilent Technologies, Drive DeVilbiss Healthcare, InvacAre Corporation, Canada Medical Ltd., Medicom, Stevens Company (Canada), Smiths Medical, FLOWTRONIX.

North America was the largest region in the nebulizers market in 2023. Asia-Pacific was the second largest region in the global nebulizers market share. The regions covered in the nebulizers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nebulizers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain. The nebulizers market consists of sales of an air compressor, a nebulizer cup, mask, or mouthpiece, medication (either unit dose vials or bottles with measuring devices), and compressor tubing. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The main types of nebulizer devices include pneumatic nebulizers, ultrasonic nebulizers, and mesh nebulizers. A pneumatic nebulizer converts the medication solution into an aerosol of tiny droplets using a jet of compressed gas. The flow of inert gas carries the droplets to an atomizer. The market is categorized by portability into portable nebulizers and tabletop nebulizers. Various applications include treating conditions such as COPD, cystic fibrosis, asthma, and others. Nebulizer devices are used by end-users such as hospitals and clinics, emergency centers, and home healthcare settings.

The nebulizers market research report is one of a series of new reports that provides nebulizers market statistics, including nebulizers industry global market size, regional shares, competitors with a nebulizers market share, detailed nebulizers market segments, market trends and opportunities, and any further data you may need to thrive in the nebulizers industry. This nebulizers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.